Compare, Analyse Novartis with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs MYLAN (US) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   MYLAN
EQUITY SHARE DATA
    NOVARTIS
Mar-19
MYLAN
Dec-18
NOVARTIS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs9803,608-   
Low Rs6001,986-   
Sales per share (Unadj.) Rs198.71,660.0-  
Earnings per share (Unadj.) Rs21.045.1-  
Cash flow per share (Unadj.) Rs22.3355.9-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.51,795.8-  
Shares outstanding (eoy) m24.69514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.7 236.0%   
Avg P/E ratio x37.762.0 60.7%  
P/CF ratio (eoy) x35.57.9 451.8%  
Price / Book Value ratio x2.61.6 165.0%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5081,438,877 1.4%   
No. of employees `0000.635.0 1.7%   
Total wages/salary Rs m1,1710-   
Avg. sales/employee Rs Th8,445.424,402.2 34.6%   
Avg. wages/employee Rs Th2,015.70-   
Avg. net profit/employee Rs Th891.0662.6 134.5%   
INCOME DATA
Net Sales Rs m4,907854,078 0.6%  
Other income Rs m7830-   
Total revenues Rs m5,689854,078 0.7%   
Gross profit Rs m123221,004 0.1%  
Depreciation Rs m32159,917 0.0%   
Interest Rs m1641,078 0.0%   
Profit before tax Rs m85820,009 4.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340-3,183 -10.7%   
Profit after tax Rs m51823,192 2.2%  
Gross profit margin %2.525.9 9.7%  
Effective tax rate %39.6-15.9 -249.2%   
Net profit margin %10.62.7 388.5%  
BALANCE SHEET DATA
Current assets Rs m8,055476,916 1.7%   
Current liabilities Rs m1,850347,725 0.5%   
Net working cap to sales %126.415.1 835.9%  
Current ratio x4.41.4 317.4%  
Inventory Days Days4584 53.9%  
Debtors Days Days3493 36.3%  
Net fixed assets Rs m150165,677 0.1%   
Share capital Rs m123455 27.1%   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,592923,956 0.8%   
Long term debt Rs m0997,245 0.0%   
Total assets Rs m9,8242,478,409 0.4%  
Interest coverage x54.91.5 3,694.7%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.50.3 144.9%   
Return on assets %5.42.6 209.4%  
Return on equity %6.82.5 271.7%  
Return on capital %11.53.2 361.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,943177,477 -1.1%  
From Investments Rs m2,742-91,736 -3.0%  
From Financial Activity Rs m-298-82,679 0.4%  
Net Cashflow Rs m5011,470 34.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 75.79 Rs / USD

Compare NOVARTIS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: SUVEN LIFESCIENCES  ORCHID PHARMA LTD  SANOFI INDIA  DR. REDDYS LAB  VENUS REMEDIES  



Today's Market

Sensex Zooms 2,476 Points; Banking, Energy and Automobile Stocks Rally(Closing)

Indian share markets continued to trade in the green during closing hours and ended their day on a strong note.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound (The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak (Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

NOVARTIS SHARE PRICE


Apr 7, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS 5-YR ANALYSIS

COMPARE NOVARTIS WITH

OTHER USEFUL LINKS

MARKET STATS